Sunho Biologics Inc. is a biotechnology company dedicated to developing innovative therapeutic solutions for various health conditions. The company's primary focus is on leveraging cutting-edge biotechnology research to create biologic drugs that target immune system disorders and complex diseases. Sunho Biologics Inc. employs advanced technologies such as monoclonal antibodies and recombinant DNA to develop treatments that can potentially transform patient outcomes and address unmet medical needs. A significant player in the pharmaceutical and healthcare sectors, the company collaborates with academic institutions, research organizations, and other industry partners to accelerate drug development processes and enhance the scope of its research capabilities. With a commitment to quality and efficacy, Sunho Biologics Inc. has positioned itself as a pivotal contributor in the fight against chronic diseases, offering hope and improving the quality of life for patients around the globe.